Skip to main content

Day: September 5, 2025

Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market

Study to Support Potential FDA Approval via 505(b)(2) Pathway MELBOURNE, Australia, Sept. 05, 2025 (GLOBE NEWSWIRE) — Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today announced plans to commence a preclinical bioequivalence study in September 2025 to evaluate its novel gel-based formulation of a widely used antihistamine for allergy treatment. The study will be conducted by Adgyl Lifesciences (a partner of Eurofins Advinus), a leader in preclinical contract research services. If preclinical results are successful, Gelteq anticipates advancing to human clinical trials targeting U.S. Food and Drug Administration (FDA) approval via the 505(b)(2) regulatory pathway. “Our gel-based delivery platform is expected to transform traditional pharmaceutical...

Continue reading

Verizon boosts shareholder payout, marking 19th consecutive year of dividend growth

NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) — The Board of Directors at Verizon Communications Inc. (NYSE, Nasdaq: VZ) today declared a quarterly dividend of 69 cents per outstanding share, an increase of 1.25 cents per share from the previous quarter. The quarterly dividend is payable on November 3, 2025 to Verizon shareholders of record at the close of business on October 10, 2025. This 19th consecutive annual increase is a direct result of the company’s disciplined financial management and unwavering focus on long-term growth. By strategically expanding both its mobility and broadband networks to capture high-value customer segments, Verizon generates the consistent, durable cash flow necessary to reward shareholders while simultaneously investing in future innovation. “The Board and I are pleased to raise our dividend for...

Continue reading

Sify Infinit Spaces announces the appointment of Mark Adams as Non-Executive and Non-Independent Director on the Board

CHENNAI, India, Sept. 05, 2025 (GLOBE NEWSWIRE) — The Board of Sify Infinit Spaces Limited (SISL), a subsidiary of Nasdaq listed Sify Technologies Limited (Nasdaq: Sify), today welcomed global data center technology advisor, consultant and practitioner, Mr. Mark Adams, to join the Board as Non-Executive and Non-Independent Director. Mr. Adams is a global strategy and M&A executive with decades of experience specializing in Communications Infrastructure and Technology across companies. Previously, Mark was Chief Development Officer of Equinix for 10 years growing its revenue from $33.87B to $396.64B. He was responsible for Corporate Strategy, M&A and Real Estate, completing many acquisitions and overseeing Equinix’s real estate investment program. Mr. Adams is currently a Senior Advisor to Global Infrastructure Partners,...

Continue reading

No. 17/2025 – Managers’ transactions

Nasdaq Copenhagen                                                                                    Nikolaj Plads 6DK-1067 Copenhagen K    Copenhagen, 5 September 2025ANNOUNCEMENT no. 17/2025 Managers’ transactions Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 5 September 2025.Details of the person discharging managerial responsibilities/person closely associated  Name: Joanna Lucyna Iwanowska-NielsenReason for the notification:  Position/status: Member of the board of directors in Cemat A/SInitial notification/Amendment: InitialDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  Name: Cemat A/SLEI: 213800899MWAZT9KQZ78      Details of the transaction(s): section to be repeated for...

Continue reading

Inauguration of JUPITER, Europe’s most powerful supercomputer

Eviden XH3000 JUPITEREviden XH3000 JUPITER at Juliech Supercomputing CentreEviden-built AI-dedicated partition of JUPITER – the exascale partition – celebrated during an official inauguration ceremony  Paris, France – September 5, 2025 – Eviden, the Atos Group product brand leading in advanced computing, cybersecurity products, mission-critical systems and vision AI announces that the Eviden-built JUPITER Booster, a partition designed for large-scale simulations and AI training, has been inaugurated today on September 5, 2025. The event took place at the Jülich Supercomputing Centre in Germany, in the presence of Friedrich Merz, Chancellor of the Federal Republic of Germany, Hendrik Wüst, Minister-President of the State of North Rhine-Westphalia, Dorothee Bär, Federal Minister for Research, Technology and Space and Ina Brandes,...

Continue reading

DMG Blockchain Solutions Announces Preliminary August Operational Results

VANCOUVER, British Columbia, Sept. 05, 2025 (GLOBE NEWSWIRE) —  DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB: DMGGF) (FRANKFURT: 6AX) (“DMG” or the “Company”), a vertically integrated blockchain and data center technology company, today announces its preliminary operational results for August 2025:Bitcoin mined: 23 BTC (vs 26 BTC in July 2025) Hashrate: 1.53 EH/s (vs 1.65 EH/s in July 2025) Bitcoin balance: 324 BTC (vs 307 BTC in July 2025)In August 2025, DMG’s hashrate was 1.53 EH/s, compared to 1.65 EH/s in July. This decline reflects planned substation maintenance in August, resulting in about four days of scheduled downtime, with some partial operation in the evening hours that resulted in a net downtime of slightly more than three days. However, the Company’s hydro-powered miners, which were...

Continue reading

Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China

SAN DIEGO and SUZHOU, China, Sept. 05, 2025 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that ADG126 will be highlighted in two oral presentations at this year’s CSCO Meeting, taking place September 10-14 in Jinan, China. Harnessing the Power of Masked CTLA-4 Blockade: Updated ADG126-P001 Phase 1b/2Results of ADG126 + Pembrolizumab in Advanced MSS CRCPresenter:   Dr. Xu Ruihua, Professor and President of Sun Yat-sen University Cancer Center and Chairman of the Chinese Society of Clinical Oncology (CSCO)Date and Time:   Thursday, September 11 at 14:45-15:00 CST (China Standard Time)Location:   Jinan, China     Immunotherapy for mCRCPresenter:   Dr. Heinz-Josef Lenz, Chair of the...

Continue reading

No. 16/2025 – Managers’ transactions

Nasdaq Copenhagen                                                                                    Nikolaj Plads 6DK-1067 Copenhagen K    Copenhagen, 5 September 2025ANNOUNCEMENT no. 16/2025 Managers’ transactions Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 5 September 2025.Details of the person discharging managerial responsibilities/person closely associated  Name: Jarosław LipińskiReason for the notification:  Position/status: CEO in Cemat A/SInitial notification/Amendment: InitialDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  Name: Cemat A/SLEI: 213800899MWAZT9KQZ78      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type...

Continue reading

Royal Canadian Mint Announces Closing of Follow-On Offering of Gold Exchange-Traded Receipts

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OTTAWA, Ontario, Sept. 05, 2025 (GLOBE NEWSWIRE) — (TSX: MNT/MNT.U) The Royal Canadian Mint (the “Mint”) announced today that it has completed its previously-announced follow-on offering of 833,200 exchange-traded receipts (“ETRs”) under the Mint’s Canadian Gold Reserves program at a price of C$53.18 per ETR for gross proceeds of C$44,309,576 (the “Offering”). The newly-issued ETRs have been listed on the Toronto Stock Exchange and are fully fungible with all other outstanding ETRs. The Offering was made on a prospectus-exempt basis pursuant to the terms of exemptive relief orders issued in favour of the Mint by the Ontario Securities Commission. Each ETR provides its holder with direct legal and beneficial ownership in physical gold bullion...

Continue reading

No. 15/2025 – Closely related persons transactions

Nasdaq Copenhagen                                                                                    Nikolaj Plads 6DK-1067 Copenhagen K    Copenhagen, 5 September 2025ANNOUNCEMENT no. 15/2025 Closely related persons transactions Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 5 September 2025.Details of the person discharging managerial responsibilities/person closely associated  Name: Peter Tærø NielsenReason for the notification:  Position/status: Closely related person to Joanna Lucyna Iwanowska-Nielsen, member of the board of directors in the companyInitial notification/Amendment: InitialDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  Name: Cemat A/SLEI: 213800899MWAZT9KQZ78      Details...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.